National Healthcare Properties, Inc. current report, 29 March 2018

Business Context and Reporting Period

This Form 8-K filing by Healthcare Trust, Inc. (a non-listed REIT) reports the determination of the Estimated Per-Share Net Asset Value (NAV) as of December 31, 2017. The report was filed on March 29, 2018, following a unanimous approval by the independent directors of the Board on that date. The valuation was conducted by the independent third-party firm Duff & Phelps, LLC, in accordance with the Company's valuation guidelines.

Key Financial Metrics

The filing provides a detailed breakdown of the Estimated Per-Share NAV components as of December 31, 2017, based on 91,768,014 fully diluted shares outstanding.

Component Per Share Value (Dec 31, 2017) Per Share Value (Dec 31, 2016)
Real Estate Assets $29.82 $28.34
Other Assets $1.36 $0.58
Fair Value of Debt ($10.33) ($6.97)
Other Liabilities ($0.60) ($0.50)
Estimated Per-Share NAV $20.25 $21.45

Valuation Assumptions:

  • Direct Capitalization Method: Weighted average overall capitalization rate of 6.53% (range 5.50% - 8.00%).
  • Discounted Cash Flow Method: Weighted average terminal capitalization rate of 7.26% (range 5.75% - 9.50%) and discount rate of 8.39% (range 6.75% - 10.75%).

Material Changes Versus Prior Period

The Estimated Per-Share NAV decreased from $21.45 in 2016 to $20.25 in 2017. The filing attributes this decline to two primary factors:

  • Distributions vs. Cash Flow: Distributions paid to stockholders exceeded cash flows from operations by $73.6 million, negatively impacting NAV.
  • Asset Appreciation: This negative impact was partially offset by a $62.1 million increase in the value of Real Estate Assets, representing a 10.3% increase over the sum of original purchase prices and post-acquisition capital expenditures.

Guidance, Outlook, and Management Commentary

Distribution Rate Reduction: Management noted that the negative effect of distributions exceeding cash flows is expected to be significantly less in future periods. In February 2018, the Company reduced its annual distribution rate from $1.45 per share to $0.85 per share.

Valuation Range: A sensitivity analysis indicated an Estimated Per-Share NAV range of $18.38 to $20.55, with a midpoint of $19.49. The Board approved the $20.25 figure, which falls between the midpoint and the high end of the range provided by Duff & Phelps.

Repurchase and Reinvestment Plans: The new NAV of $20.25 will serve as the price per share for the Share Repurchase Program (SRP) and Distribution Reinvestment Plan (DRIP) for eligible transactions.

Risks and Limitations: The filing emphasizes that the Estimated Per-Share NAV does not reflect a liquidity discount, costs of sale, or enterprise value. It is not a guarantee of future performance or the price a third party would pay for the Company's shares.

Important Facts for Investor Verification

  • NAV Decline: Verify the impact of the $73.6 million excess distribution payout on the reduction of NAV from $21.45 to $20.25.
  • Distribution Cut: Confirm the operational impact of the February 2018 reduction in the annual distribution rate from $1.45 to $0.85 per share.
  • Valuation Methodology: Review the specific capitalization and discount rates (6.53% and 8.39% weighted averages) used by Duff & Phelps to ensure they align with current market conditions for healthcare real estate.
  • Debt Levels: Note the increase in the per-share fair value of debt from $6.97 to $10.33, reflecting changes in the Company's leverage profile.
  • Liquidity Constraints: Acknowledge that the NAV does not account for a liquidity discount, as the shares are not traded on a national securities exchange.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.